Patrick Mcphail Martin

TitleAssociate Professor



Please, update Activity Insight. No 'Fax Number' has been entered for this faculty member.

OfficeSmith Hall
Room: 2002

1601 East Market Street
Greensboro, NC 27411

Patrick Mcphail Martin


Ph D: Cell Biology, University of Virginia, 2003

BS: Biology, Virginia Union University, 1997

Research Interests

brain and breast tumor research, cancer health disparities, research training education

Recent Publications

Baines, Antonio   Martin, Patrick   Rorie, Checo  (2016).  Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.  In Kevin Pruitt,  Molecular and Cellular Changes in the Cancer Cell  (144,  pp. 277-320).

Sandhaus, S  Taylor, R  Edwards, T  Huddleston, A  Wooten, Y  Venkatraman, R  Weber, R  González-Sarrías, A  Martin, Patrick  Cagle, P  Tse-Dinh, Y  Beebe, S  Seeram, N  Holder, A  (2016).  A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIα..  (64,  pp. 45-49).  Inorganic chemistry communications.

Williams, Jennie  Lewis-Alleyne,  Lesley  Solomon, Melinda   Nguyen, Long   Johnson, Robert   Vital , Jennifer  Ji, Ping   Durrant, John   Cooper, Camille   Cagle, Patrice  Martin, Patrick  VanDerveer, Don  Jarrett, William   Holder, Alvin   (2016).  An in vitro study on the effect of synthesized tin(IV) complexes on glioblastoma, colorectal and skin cancer cell lines..  (1,  1,  pp. 7-15).

Mahdavian, E  Marshall, M  Martin, Patrick  Cagle, P  Salvatore, B  Quick, Q  (2014).  Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanone..  (3,  34,  pp. 880-5).  International journal of molecular medicine.

Martin, Patrick  (2014).  contributing author.   Molecular Medicine Reports.

González, I  Martin, Patrick  Burdsal, C  Sloan, J  Mager, S  Harris, T  Sutherland, A  (2012).  Leucine and arginine regulate trophoblast motility through mTOR-dependent and independent pathways in the preimplantation mouse embryo..  (2,  361,  pp. 286-300).  Developmental biology.

Uht, R  Amos, S  Martin, Patrick  Riggan, A  Hussaini, I  (2007).  The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway..  (20,  26,  pp. 2885-93).  Oncogene.

Martin, Patrick  Aeder, S  Chrestensen, C  Sturgill, T  Hussaini, I  (2007).  Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta..  (3,  26,  pp. 407-14).  Oncogene.

Martin, Patrick  Hussaini, I  (2005).  PKC eta as a therapeutic target in glioblastoma multiforme..  (2,  9,  pp. 299-313).  Expert opinion on therapeutic targets.

Amos, S  Martin, Patrick  Polar, G  Parsons, S  Hussaini, I  (2005).  Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells..  (9,  280,  pp. 7729-38).  The Journal of biological chemistry.